A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)

PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 4, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Alcohol Hepatitis
Interventions
DRUG

ADX-629

125 mg twice daily for 28 days

DRUG

ADX-629

250 mg twice daily for 28 days

Trial Locations (6)

23221

RECRUITING

Bon Secours Liver Institute of Newport News, Richmond

33606

RECRUITING

Florida Health Sciences Center/Tampa General Hospital/USF, Tampa

34209

RECRUITING

Synergry Healthcare, Bradenton

75203

RECRUITING

The Liver Institute at Methodist Dallas Medical Center, Dallas

77057

RECRUITING

UDL Clinical Research, LLC, Houston

78229

RECRUITING

Methodist Specialty and Transplant Hospital, San Antonio

Sponsors
All Listed Sponsors
lead

Aldeyra Therapeutics, Inc.

INDUSTRY